Pediatrix Medical Group, Inc. Earnings Per Share Disclosure
14. Common and Common Equivalent Shares:
The calculation of shares used in the basic and diluted net income per share calculation for the years ended December 31, 2025, 2024, and 2023 is as follows (in thousands):
|
|
Years Ended December 31, |
|
|||||||||
|
|
2025 |
|
|
2024 |
|
|
2023 |
|
|||
Weighted average number of common |
|
|
84,080 |
|
|
|
83,330 |
|
|
|
82,201 |
|
Weighted average number of dilutive common |
|
|
1,188 |
|
|
|
— |
|
|
|
— |
|
Weighted average number of common and common |
|
|
85,268 |
|
|
|
83,330 |
|
|
|
82,201 |
|
Antidilutive restricted stock not included in the diluted net income per common share calculation |
|
|
99 |
|
|
|
333 |
|
|
|
1,115 |
|
(a) Due to a loss for the years ended December 31, 2024 and 2023, 0.6 million and 0.4 million incremental shares, respectively, are not included because the effect would be antidilutive.
Want the next Pediatrix Medical Group, Inc. earnings per share disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Pediatrix Medical Group, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 19, 2026 | Showing above |
| 2024 | Feb 20, 2025 | |
| 2023 | Feb 20, 2024 | |
| 2022 | Feb 17, 2023 | |
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.